A promising new technology for Parkinson's disease.

A promising new technology for Parkinson's disease.

Item
http://www.wikidata.org/entity/Q36200742
Single dose pharmacokinetics of the transdermal rotigotine patch in patients with impaired renal function.Motor and nonmotor complications in Parkinson's disease: an argument for continuous drug delivery?Rotigotine transdermal system: a short review.Pharmacokinetics, safety and tolerability of rotigotine transdermal patch in healthy Japanese and Caucasian subjects.Oral and infusion levodopa-based strategies for managing motor complications in patients with Parkinson's disease.Levodopa delivery systems: advancements in delivery of the gold standard.Rotigotine transdermal delivery for the treatment of restless legs syndrome.Drug safety evaluation of rotigotine.ADMET considerations when prescribing novel therapeutics to treat restless legs syndrome.Rotigotine transdermal patch and sleep in Parkinson's disease: where are we now?Continuous levodopa for advanced Parkinson's disease.Influence of domperidone on pharmacokinetics, safety and tolerability of the dopamine agonist rotigotine.
P2860

A promising new technology for Parkinson's disease.

Item
http://www.wikidata.org/entity/Q36200742
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
A promising new technology for Parkinson's disease.
@ast
A promising new technology for Parkinson's disease.
@en
type
label
A promising new technology for Parkinson's disease.
@ast
A promising new technology for Parkinson's disease.
@en
prefLabel
A promising new technology for Parkinson's disease.
@ast
A promising new technology for Parkinson's disease.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
A promising new technology for Parkinson's disease.
@en
P2093
P304
P31
P356
10.1212/WNL.65.2_SUPPL_1.S6
P407
P433
P478
P577
P698
P921